Tech Company Financing Transactions
Inform Genomics Funding Round
Inform Genomics, based in Boston, secured investment capital from private investors.
Transaction Overview
Company Name
Announced On
12/1/2011
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Inform Genomics said that it would use the new capital mainly to move along development of its molecular diagnostic product called ONPART, which uses genomics to predict what side effects a specific cancer patient might encounter with chemotherapy treatments.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
75 Federal St. 1900
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Website
Email Address
Not Recorded
Overview
Our vision is to transform individual patient care & drug development with our predictive pharmacogenomic platform of products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ed Rubenstein
Browse more venture capital transactions:
Prev: 12/1/2011: Academia venture capital transaction
Next: 12/1/2011: AboutOne venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record funding rounds that are announced publicly. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs